How Pharmaceutical Companies Affect the Healthcare System Yan Li‚ Ying Li‚ Nancy Nycum‚ Maria Rubi‚ Cristina Sanchez Florida International University Executive Summary The Pharmaceutical industry has been around since the Middle Ages‚ and it has affected healthcare in many ways. The development of medicine and having a scientific approach‚ while being able to understand the human biology such as DNA‚ has helped achieve miracles. One of the most well known pharmaceutical companies Pfizer has
Premium Food and Drug Administration Pharmaceutical industry Drug development
BMI View: Data released by the Turkish drugmakers association for 2013 sales corresponds with our own forecasts. We have also modified our pharmaceutical sales forecast for 2014 and beyond to reflect the volatile exchange rate situation. We now see Turkey’s lustre as an emerging pharmaceutical market regressing over the medium term. We believe that the business environment will continue to impede the industry and see very little scope for the central government to enact business-friendly reform in
Free Pharmacology Food and Drug Administration Medicine
this paper is to analyze federal antitrust enforcers are investigating whether a multinational pharmaceutical company has attempted to minimize the impact of generic competition to one of its most profitable prescription drugs. This anti-depressant drug is the company’s best seller‚ with sales last year of $2.11 billion‚ representing a 22% increase from the year before. I will review whether pharmaceutical companies have engaged in activities that will prevent generic brands to the prescription drug
Premium Pharmacology Generic drug Food and Drug Administration
Teva Pharmaceuticals Strategy Overview 4/22/2013 PARTHIBAN SELVAM SMU MBA 2013 Business Overview: Teva Pharmaceuticals is a pharmaceutical company specializing in generic and proprietary drugs. It is the world’s 11th biggest pharmaceutical company. Apart from its major market‚ US and Europe‚ it has a major presence in Russia‚ Latin America‚ Japan and South Korea. In 2012‚ it had revenue of 20.3 billion and a net income of 1.96 billion (see table 1). Target Customers: Teva pharmaceutical’s
Premium Generic drug Pharmaceutical industry Pharmacology
Domestic drug manufacturers have cast their eyes overseas for growth and four of them have received the certificate of pharmaceutical product (CPP)‚ one of the pre-requisites for obtaining an export licence from the Department of Drug Administration (DDA). According to the DDA‚ Lomus Pharmaceuticals‚ Deurali-Janata Pharmaceuticals‚ Elder Pharmaceuticals and National Health Care Nepal have received the CPP. The CPP is a must for drug manufacturers wanting to export their products. Once the CPP has
Premium Pharmacology Pharmaceutical drug Drug
RESEARCH AND DEVELOPMENT SCENARIO IN INDIAN PHARMACEUTICAL COMPANIES SUBMITED BY: MR. SHAMSHAD AH DEPARTMENT OF PHARMACEUTICAL MANAGEMENT DEPARTMENT OF PHARMACEUTICAL MANAGEMENT NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH SEC. NO. 67‚ S.A.S. NAGAR MOHLI PUNJAB CONTENTS: * OBJECTIVES....................................................................................3 * INTRODUCTION.............................................................................3
Premium Pharmaceutical industry Clinical trial Drug discovery
Problems Faced by Small and Medium Pharmaceutical Companies Small and medium enterprises (SMEs) in their endeavour towards trans-nationalization and exports are confronted with several issues. These include: lack of expertise‚ training and finance for technological up-gradation and adoption of good manufacturing practices (GMP) by SMEs to meet global quality standards; limited exposure and expertise on IPR issues; limited adoption of information technology (IT) techniques in production and processes;
Premium Pharmacology Pharmaceutical industry Drug
According to the first class‚ the power point showed that the pharmaceutical industry is the most profitable industry. Based on the Porter’s five forces model‚ there are convincing explanation why the pharmaceutical industry has big profitability. For the threat of new entrants perspective‚ it is high. The pharmaceutical industry has a big barrier to prevent newcomers to enter this industry such as R&D costs‚ patents limitation‚ the long length of clinical time‚ the percentage of FDA to approve drug
Premium Pharmaceutical industry Pharmacology Mergers and acquisitions
IBUS 3312 - International Management Pharmaceutical Companies‚ Intellectual Property‚ and the Global AIDS Epidemic Analysis While this case is literally full of negative aspects‚ we will only focus on the main points for both arguments. Pharmaceutical companies want to be sure that the products they spend years and millions of dollars to create are not easily reproduced and sold at discount prices. The profits pharmaceuticals make of their patented products are supposed to refinance
Premium United Nations AIDS Developing country
Deontological Ethical Analysis of Direct-to-Consumer Pharmaceutical Marketing In Deontological ethics‚ morality of an action is based upon the particular action’s adherence to moral laws independent of their consequences (DeGeorge 62). Direct-to-consumer marketing of pharmaceuticals has had heated debate with logical arguments from those for‚ and for those against allowing such practices to exist. I do not believe the marketing of the prescription medication to be solely unethical but more
Premium Marketing Pharmacology Pharmaceutical industry